First-Line PD-1 Inhibitor-Based Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma: A Revised Systematic Review and Meta-Analysis of Phase III Trials.

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://www.ncbi.nlm.nih.gov/pubmed/42702772

Björn Erik Ole Jensen; Christoph Roderburg; Edwin Bölke; Guangyu Lu; Ilyas Gencer; Johannes C Fischer; Muemtaz Koeksal; Torsten Feldt; Vincent Rothweiler; Wilfried Budach; Wolfram Trudo Knoefel

Sep 8, 2026